These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2905121)

  • 1. Immunohistochemical analysis of suppressor-inducer and helper-inducer T cells in multiple sclerosis brain tissue.
    Sobel RA; Hafler DA; Castro EE; Morimoto C; Weiner HL
    Ann N Y Acad Sci; 1988; 540():306-8. PubMed ID: 2905121
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of functional suppression is linked to decreases in circulating suppressor-inducer (CD4+ 2H4+) T cells in multiple sclerosis.
    Chofflon M; Weiner HL; Hafler DA
    Ann N Y Acad Sci; 1988; 540():330-2. PubMed ID: 2905122
    [No Abstract]   [Full Text] [Related]  

  • 3. Decrease of suppressor inducer (CD4+2H4+) T cells in multiple sclerosis cerebrospinal fluid.
    Chofflon M; Weiner HL; Morimoto C; Hafler DA
    Ann Neurol; 1989 May; 25(5):494-9. PubMed ID: 2528316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressor-inducer T-cells in multiple sclerosis.
    Rose LM; Ledbetter JA; Ginsberg AH; Clark EA; Rothstein TL
    N Engl J Med; 1987 Jul; 317(2):118-9. PubMed ID: 2953974
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of T lymphocytes, T helper and T suppressor, in multiple sclerosis. Preliminary report].
    Tilbery CP; Lima JG; Scheinberg MA; Santos LM; Yamada FT
    Rev Paul Med; 1984; 102(4):181-3. PubMed ID: 6240108
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphocyte phenotypes in the multiple sclerosis lesion--what do they mean?
    Zweiman B; Lisak RP
    Ann Neurol; 1986 Jun; 19(6):588-9. PubMed ID: 2942098
    [No Abstract]   [Full Text] [Related]  

  • 7. Monocyte defect causes decreased autoMLR in multiple sclerosis patients.
    Baxevanis CN; Reclos GJ; Arsenis P; Katsiyiannis A; Matikas N; Papamichail M
    Adv Exp Med Biol; 1988; 237():839-42. PubMed ID: 2908171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-lymphocyte subsets defined by double immunofluorescence in multiple sclerosis.
    Ilonen J; Surcel HM; Jägerroos H; Nurmi T; Reunanen M
    Acta Neurol Scand; 1990 Feb; 81(2):128-30. PubMed ID: 2139295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of circulating suppressor inducer T lymphocytes in the exacerbation phase of remitting-relapse multiple sclerosis.
    Cafaro A; Spadaro M; Pandolfi F; Tilia G; Scarselli E; Liberati F; Aiuti F
    Riv Neurol; 1987; 57(3):159-62. PubMed ID: 2960006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease of CD4+CD45+ T-cells in chronic-progressive multiple sclerosis.
    Zaffaroni M; Rossini S; Ghezzi A; Parma R; Cazzullo CL
    J Neurol; 1990 Feb; 237(1):1-4. PubMed ID: 1969461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic progressive multiple sclerosis: changes in phenotype and function of T helper subsets.
    O'Gorman MR; Aziz T; Oger J
    J Neuroimmunol; 1989 Sep; 24(1-2):163-8. PubMed ID: 2530247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2H4 (CD45R) antigen is selectively decreased in multiple sclerosis lesions.
    Sobel RA; Hafler DA; Castro EE; Morimoto C; Weiner HL
    J Immunol; 1988 Apr; 140(7):2210-4. PubMed ID: 2965183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid and peripheral blood T-lymphocyte subsets in multiple sclerosis: monoclonal antibody analysis and correlations with clinical activity.
    Salmaggi A; Bianchi G; Cerrato D; Lazzaroni M; Malesani L; Nespolo A; Corridori F; La Mantia L; Milanese C
    Ital J Neurol Sci; 1987 Aug; 8(4):327-30. PubMed ID: 2960634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoregulation in multiple sclerosis.
    Weiner HL; Hauser SL
    Prog Brain Res; 1983; 59():339-43. PubMed ID: 6229809
    [No Abstract]   [Full Text] [Related]  

  • 15. Possible in vivo modulation of Leu 2a expression on suppressor T cells in active multiple sclerosis.
    Thompson AJ; Brazil J; Whelan CA; Feighery C
    Immunol Lett; 1985; 10(3-4):189-91. PubMed ID: 2931357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.
    Batoulis H; Addicks K; Kuerten S
    Ann Anat; 2010 Aug; 192(4):179-93. PubMed ID: 20692821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA typing and T-cell subpopulations in multiple sclerosis.
    Zaffaroni M; Di Falco M; Ghezzi A; Rizzolo L; Veneroni G; Marforio S
    J Neurol Neurosurg Psychiatry; 1988 Nov; 51(11):1465. PubMed ID: 2976813
    [No Abstract]   [Full Text] [Related]  

  • 18. Is the decrease in suppressor inducer T cells in multiple sclerosis specific?
    Elias SB
    Ann Neurol; 1990 Apr; 27(4):447-8. PubMed ID: 2141242
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphocyte subsets in the cerebrospinal fluid in active multiple sclerosis.
    Salonen R; Ilonen J; Jägerroos H; Syrjälä H; Nurmi T; Reunanen M
    Ann Neurol; 1989 May; 25(5):500-2. PubMed ID: 2528317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant augmentation of CD4+ CD29+ helper inducer and diminution of CD4+ CD45RA+ suppressor inducer subset in patients infected with human T cell lymphotropic virus types I or II.
    Lal RB; Rudolph DL; Schmid DS; Lairmore MD
    Clin Exp Immunol; 1992 Feb; 87(2):293-7. PubMed ID: 1370929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.